CLINICAL GUIDELINES - HCSC

2y ago
126 Views
2 Downloads
642.84 KB
64 Pages
Last View : 1m ago
Last Download : 3m ago
Upload by : Mariam Herr
Transcription

CLINICAL GUIDELINESCardiac Imaging PolicyVersion 20.0.2018Effective June 1, 2018eviCore healthcare Clinical Decision Support Tool Diagnostic Strategies: This tool addresses common symptoms and symptom complexes. Imaging requests for individualswith atypical symptoms or clinical presentations that are not specifically addressed will require physician review. Consultation with the referring physician, specialist and/orindividual’s Primary Care Physician (PCP) may provide additional insight.CPT (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT five digit codes, nomenclature and other data arecopyright 2016 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in the CPT book. AMA doesnot directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein. 2018 eviCore healthcare. All rights reserved.

Imaging GuidelinesV20.0.2018Cardiac Imaging Guidelines34516273442475056596264Cardiac ImagingAbbreviations For Cardiac Imaging GuidelinesGlossaryCD-1: General GuidelinesCD-2: Echocardiography (ECHO)CD-3: Nuclear Cardiac ImagingCD-4: Cardiac CT, Coronary CTA, and CT for CoronaryCalcium(CAC)CD-5: Cardiac MRICD-6: Cardiac PETCD-7: Diagnostic Heart CatheterizationCD-8: Pulmonary Artery and Vein ImagingCD-9: Congestive Heart FailureCD-10: Cardiac TraumaCD-11: CAD 2018 eviCore healthcare. All Rights Reserved.Page 2 of 64400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924www.eviCore.com

Imaging merican College of Cardiologyacute coronary syndromeAmerican Heart AssociationAnglo-Scandinavian Cardiac Outcomes Trialatrial septal defectbody mass indexcoronary artery bypass graftingcoronary artery diseasecongestive heart failurechronic obstructive pulmonary diseasecomputed tomographycoronary computed tomography angiographycomputed tomography angiographyelectron beam computed tomographyexternal counterpulsation (also known as EECP)electrocardiogramexternal counterpulsationexercise treadmill stress testFluorodeoxyglucose,a radiopharmaceutical used to measure myocardialmetabolismhypertrophic cardiomyopathyintravenousleft anterior descending coronary arterylow density lipoprotein cholesterolleft heart catheterizationleft ventricleleft ventricular ejection fractionmyocardial infarctionmyocardial perfusion imaging (SPECT study, nuclear cardiac study)magnetic resonance angiographymagnetic resonance imagingmillisievert (a unit of radiation exposure) equal to an effective dose of a joule ofenergy per kilogram of recipient massmulti gated acquisition scan of the cardiac blood poolpercutaneous coronary intervention (includes percutaneous coronaryangioplasty (PTCA) and coronary artery stenting)positron emission tomographypercutaneous coronary angioplastyright heart catheterizationsingle photon emission computed tomographytransesophageal echocardiogramTransient Ischemic Attackventricular septal defect 2018 eviCore healthcare. All Rights Reserved.Page 3 of 64400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924www.eviCore.comCardiac ImagingAbbreviations for Cardiac Imaging Guidelines

Imaging GuidelinesV20.0.2018GlossaryAgatston Score: a nationally recognized calcium score for the coronary arteriesbased on Hounsfield units and size (area) of the coronary calciumAngina: principally chest discomfort, exertional (or with emotional stress) and relievedby rest or nitroglycerineAnginal variants or equivalents: a manifestation of myocardial ischemia which isperceived by patients to be (otherwise unexplained) dyspnea, unusual fatigue, moreoften seen in women and may be unassociated with chest painARVD/ARVC – Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: apotentially lethal inherited disease with syncope and rhythm disturbances, includingsudden death, as presenting manifestationsBNP: B-type natriuretic peptide, blood test used to diagnose and track heart failure(n-T-pro-BNP is a variant of this test)Brugada Syndrome: an electrocardiographic pattern that is unique and might be amarker for significant life threatening dysrhythmiasDouble Product (Rate Pressure Product): an index of cardiac oxygen consumption,is the systolic blood pressure times heart rate, generally calculated at peak exercise;over 25000 means an adequate stress load was performedFabry’s Disease: an infiltrative cardiomyopathy, can cause heart failure andarrhythmiasHibernating myocardium: viable but poorly functioning or non-functioningmyocardium which likely could benefit from intervention to improve myocardial bloodsupplyOptimized Medical Therapy should include (where tolerated): antiplatelet agents,calcium channel antagonists, partial fatty acid oxidase inhibitors (e.g. ranolazine),statins, short-acting nitrates as needed, long-acting nitrates up to 6 months after anacute coronary syndrome episode, beta blocker drugs (optional), angiotensinconverting enzyme (ACE) inhibitors/angiotensin receptor blocking (ARB) agents(optional)Silent ischemia: cardiac ischemia discovered by testing only and not presenting as asyndrome or symptomsSyncope: loss of consciousness; near-syncope is not syncopeTakotsubo cardiomyopathy: apical dyskinesis oftentimes associated with extremestress and usually thought to be reversibleTroponin: a marker for ischemic injury, primarily cardiac 2018 eviCore healthcare. All Rights Reserved.Page 4 of 64400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924www.eviCore.comCardiac ImagingPlatypnea: shortness of breath when upright or seated (the opposite of orthopnea)and can indicate cardiac malformations, shunt or tumor

Imaging GuidelinesV20.0.2018CD-1: General Guidelines688810111212Cardiac ImagingCD-1.1: General Issues – CardiacCD-1.2: Stress Testing without Imaging – ProceduresCD-1.3: Stress Testing with Imaging – ProceduresCD-1.4: Stress Testing with Imaging – IndicationsCD-1.5: Stress Testing with Imaging – PreoperativeCD-1.6: Transplant PatientsCD-1.7: Non-imaging Heart Function and Cardiac Shunt ImagingCD-1.8: Genetic lab testing in the evaluation of CAD 2018 eviCore healthcare. All Rights Reserved.Page 5 of 64400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924www.eviCore.com

Imaging GuidelinesV20.0.2018Practice Estimate of Effective Radiation Dose chart for SelectedImaging StudiesIMAGING STUDYSestamibi myocardial perfusion study (MPI)Estimate of EffectiveRadiation Dose9-12 mSvPET myocardial perfusion study:Rubidium-823 mSVNH32 mSVThallium myocardial perfusion study (MPI)22-31 mSvDiagnostic conventional coronary angiogram (cath)5-10 mSvComputed tomography coronary angiography (CTCA)5-15 mSv(with prospective gating)Less than 5 mSvCT of Abdomen and pelvis8-14 mSvChest x-ray 0.1 mSvCD-1.1: General Issues – Cardiac A current clinical evaluation (within 60 days) is required prior to consideringadvanced imaging, which includes: Relevant history and physical examination and appropriate laboratory studiesand non-advanced imaging modalities, such as recent ECG (within 60 days),chest x-ray or ECHO/ultrasound, after symptoms started or worsened. Effort should be made to obtain copies of reported “abnormal” ECG studies inorder to determine whether the ECG is uninterpretable. Most recent previous stress testing and its findings Other meaningful contact (telephone call, electronic mail or messaging) by anestablished patient can substitute for a face-to-face clinical evaluation. Vital signs, height and weight or BMI or description of general habitus is needed. Advanced imaging should answer a clinical question which will affectmanagement of the patient’s clinical condition. Assessment of coronary artery disease can be determined by the following: Typical angina (definite): Substernal chest discomfort (generally described as pressure, heaviness,burning, or tightness) Generally brought on by exertion or emotional stress and relieved by rest 2018 eviCore healthcare. All Rights Reserved.Page 6 of 64400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924www.eviCore.comCardiac Imaging Cardiac imaging is not indicated if the results will not affect patient managementdecisions. If a decision to perform cardiac catheterization or other angiography hasalready been made, there is often no need for imaging stress testing.

Imaging GuidelinesV20.0.2018 May radiate to the left arm or jawWhen clinical information is received indicating that a patient isexperiencing chest pain that is "exertional" or "due to emotional stress",this meets the typical angina definition under the Pre-Test Probability Grid.No further description of the chest pain is required (location within thechest is not required). The Pre-Test Probability Grid (Table 1) is based on age, gender, andsymptoms. All factors must be considered in order to approve for stresstesting with imaging using the Pre-Test Probability Grid. Atypical angina (probable): Chest pain or discomfort (arm or jaw pain) thatlacks one of the characteristics of definite or typical angina. Non-anginal chest pain: Chest pain or discomfort that meets one or none ofthe typical angina characteristics. Anginal variants or equivalents: a manifestation of myocardial ischemiawhich is perceived by patients to be (otherwise unexplained) dyspnea,unusual fatigue, more often seen in women and may be unassociated withchest pain.Table 1:Age (years)Gender39 andyoungerMenTypical /DefiniteAnginaPectorisIntermediateWomen40 - 4950 - 5960 and overAtypical /ProbableAngina PectorisNonanginalChest PainAsymptomaticIntermediateLowVery lowIntermediateVery lowVery lowVery iateLowVery lowVery iateIntermediateLowVery rmediateIntermediateLowHighGreater than 90% pre-test probabilityIntermediateBetween 10% and 90% pre-test probabilityLowBetween 5% and 10% pre-test probabilityVery LowLess than 5% pre-test probability 2018 eviCore healthcare. All Rights Reserved.Page 7 of 64400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924www.eviCore.comCardiac ImagingPre-Test Probability of CAD by Age, Gender, and Symptoms

Imaging GuidelinesV20.0.2018CD-1.2: Stress Testing without Imaging – ProceduresThe Exercise Treadmill Test (ETT) is without imaging. Necessary components of an ETT include: ECG that can be interpreted for ischemia. Patient capable of exercise on a treadmill or similar device (generally at 4 METsor greater; see functional capacity below). An abnormal ETT (exercise treadmill test) includes any one of the following: ST segment depression (usually described as horizontal or downsloping, greateror equal to 1.0 mm below baseline) Development of chest pain Significant arrhythmia (especially ventricular arrhythmia) Hypotension Functional capacity greater than or equal to 4 METs equates to the following: Can walk four blocks without stopping Can walk up a hill Can climb one flights of stairs without stopping Can perform heavy work around the housePractice NoteAn observational study found that, compared with the Duke Activity Status Index,subjective assessment by clinicians generally underestimated exercise capacity (seereference 25).CD-1.3: Stress Testing with Imaging-Procedures Imaging Stress Tests include any one of the following: Stress Echocardiography (see CD-2.6: Stress Echocardiography (StressEcho) – Coding) MPI (see CD-3.1: Myocardial Perfusion Imaging (MPI) – Coding) Stress perfusion MRI (see CD-5.3: Cardiac MRI – Indications for Stress MRI) Stress testing with imaging can be performed with maximal exercise or chemicalstress (dipyridamole, dobutamine, adenosine, or regadenoson) and does not alterthe CPT codes used to report these studies. Stress echo, MPI or stress MRI, can be considered for the following: New, recurrent or worsening cardiac symptoms AND with any of the following: High pretest probability (greater than 90% probability of CAD) per Table 1 A history of CAD based on: A prior anatomic evaluation of the coronaries OR A history of CABG or PCI Evidence or high suspicion of ventricular tachycardia Age 40 years or greater and known diabetes mellitus Coronary calcium score / 100 2018 eviCore healthcare. All Rights Reserved.Page 8 of 64400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924www.eviCore.comCardiac ImagingCD-1.4: Stress Testing with Imaging – Indications

V20.0.2018 Poorly controlled hypertension defined as systolic BP greater than or equal to180mmhg, if provider feels strongly that CAD needs evaluation prior to BPbeing controlled. ECG is uninterpretable for ischemia due to any one of the following: Complete Left Bundle Branch Block (bifasicular block involving rightbundle branch and left anterior hemiblock does not render ECGuninterpretable for ischemia) Ventricular paced rhythm Pre-excitation pattern such as Wolff-Parkinson-White Greater or equal to 1.0 mm ST segment depression (NOT nonspecificST/T wave changes) LVH with repolarization abnormalities, also called LVH with strain (NOTwithout repolarization abnormalities or by voltage criteria) T wave inversion in the inferior and/or lateral leads. This includes leads II,AVF, V5 or V6. (T wave inversion isolated in lead III or T wave inversion inlead V1 and V2 are not included). Patient on digitalis preparation Continuing symptoms in a patient who had a normal or submaximal exercisetreadmill test and there is suspicion of a false negative result. Patients with recent equivocal, borderline, or abnormal stress testing whereischemia remains a concern. Heart rate less than 50 bpm in patients on beta blocker and/or calciumchannel blocker medication where it is felt that the patient may not achieve anadequate workload for a diagnostic exercise study. Inadequate ETT: Physical inability to achieve target heart rate (85% MPHR or 220-age.Target heart rate is calculated as 85% of the maximum age predictedheart rate (MPHR). MPHR is estimated as 220 minus the patient's age. History of false positive exercise treadmill test: a false positive ETT is onethat is abnormal however the abnormality does not appear to be due tomacrovascular CAD. Within 3 months of an acute coronary syndrome (e.g. ST segment elevation MI[STEMI], unstable angina, non-ST segment elevation MI [NSTEMI]), one MPI canbe performed to evaluate for inducible ischemia if all of the following related tothe most recent acute coronary event apply: Individual is hemodynamically stable No recurrent chest pain symptoms and no signs of heart failure No prior coronary angiography or imaging stress test in regards to the currentepisode of symptoms Assessing myocardial viability in patients with significant ischemic ventriculardysfunction (suspected hibernating myocardium) and persistent symptoms orheart failure such that revascularization would be considered. Note: MRI, cardiac PET, MPI, or Dobutamine stress echo can be used toassess myocardial viability depending on physician preference. 2018 eviCore healthcare. All Rights Reserved.Page 9 of 64400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924www.eviCore.comCardiac ImagingImaging Guidelines

Imaging Guidelines V20.0.2018 PET and MPI perfusion studies are usually accompanied by PET metabolicexaminations (CPT 78459). Tl-201 MPI perfusion studies may assessviability without accompanying PET metabolism information.Unheralded syncope (not near syncope)Asymptomatic patient with an uninterpretable ECG that: Has never been evaluated or Is a new uninterpretable change.Patient with an elevated cardiac troponin.One routine study 2 years or more after a stent Except with a left main stent where it can be done at 1 year.One routine study at 5 years or more after CABG, without cardiac symptoms.Every 2 years if there was documentation of previous “silent ischemia” on theimaging portion of a stress test but not on the ECG portion.To assess for CAD prior to starting a Class IC antiarrhythmic agent (flecainide orpropafenone) and annually while taking the medication.Prior anatomic imaging study (coronary angiogram or CCTA) demonstratingcoronary stenosis in a major coronary branch, which is of uncertain functionalsignificance, can have one stress test with imaging. Evaluating new, recurrent, or worsening left ventricular dysfunction/CHF (see CD9.1: CHF– Imagingfor additional indications). There are 2 steps that determine the need for imaging stress testing in (stable) preoperative patients: Would the patient qualify for imaging stress testing independent of plannedsurgery? If yes, proceed to stress testing guidelines; If no, go to step 2 Is the surgery considered high, moderate or low risk? (see Table 2) If high ormoderate-risk, proceed below. If low-risk, there is no evidence to determine aneed for preoperative cardiac testing. High Risk Surgery: All patients in this category should receive an imagingstress test if there has not been an imaging stress test within 1 year*, unlessthe patient has developed new cardiac symptoms or a new change in theEKG since the last stress test. Intermediate Surgery: One or more risk factors and unable to perform anETT per guidelines if there has not been an imaging stress test within 1 year*unless the patient has developed new cardiac symptoms or a new change inthe EKG since the last stress test. Low Risk: Preoperative imaging stress testing is not supported. Clinical Risk Factors (for cardiac death & non-fatal MI at time of non-cardiacsurgery) Planned high risk surgery (open surgery on the aorta or open peripheralvascular surgery) History of ischemic heart disease (previous MI, previous positive stress test,use of nitroglycerin, typical angina, ECG Q waves, previous PCI or CABG) 2018 eviCore healthcare. All Rights Reserved.Page 10 of 64400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924www.eviCore.comCardiac ImagingCD-1.5: Stress Testing with Imaging - Preoperative

Imaging GuidelinesV20.0.2018 History of compensated previous congestive heart failure (history of heartfailure, previous pulmonary edema, third heart sound, bilateral rales, chest xray showing heart failure) History of previous TIA or stroke Diabetes Mellitus Creatinine level 2 mg/dL*Time interval is based on consensus of eviCore executive cardiology panel.Table 2Cardiac Risk Stratification ListHigh Risk ( 5%) Open aortic and other majoropen vascular surgery Open peripheral vascularsurgeryIntermediate Risk (15%)Low Risk ( 1%) Open intraperitonealand/or intrathoracicsurgery Endoscopicprocedures Open carotidendarterectomy Cataract surgery Head and necksurgery Ambulatory surgery Open orthopedicsurgery Open prostatesurgery Superficial procedures Breast surgery Laparoscopic andendovascularprocedures that areunlikely to requirefurther extensivesurgical intervention Stress Testing in patients for Non-Cardiac Transplant Individuals who are candidates for any type of organ bone marrow or stem celltransplant can undergo imaging stress testing every year (usually stress echo orMPI) prior to transplant. Individuals who have undergone organ transplant are at increased risk forischemic heart disease secondary to their medication. Risk of vasculopathy is 7%at one year, 32% at five years and 53% at ten years. An imaging stress test canbe repeated annually after transplant for at least two years or within one year of aprior cardiac imaging study if there is evidence of progressive vasculopathy. After two consecutive normal imaging stress tests, repeated testing is notsupported more often than every other year without evidence for progressivevasculopathy or new symptoms. St

A current clinical evaluation (within 60 days) is required prior to considering advanced imaging, which includes: Relevant history and physical examination and appropriate laboratory studies and non-advanced imaging modalities, such as recent ECG (within 60days), chest x-ra

Related Documents:

2/3/2012 4 7 Course Content Interactive Scenarios Timely Examples Knowledge Checks 8 Lessons Learned Board Members are not all that different from employees. Course must be challenging, but not burdensome. Course must be customized to HCSC business. Course must include exa

Chemical Pathology Clinical Guidelines 21 Laboratory Information 125 Immunology Clinical Guidelines 22 Laboratory Information 147 Microbiology Clinical Guidelines 75 Laboratory Information 159 Histopathology, Cytology, Neuropathology &Molecular Pathology Clinical Guidelines 81 Laboratory Information 166 NHISSOT Clinical Guidelines 84

The Clinical Program is administered by the Clinical Training Committee (CTC) under the leadership of the Director of Clinical Training (DCT) and the Associate Director of Clinical Training (ADCT). The program consists of three APA defined Major Areas of Study: Clinical Psychology (CP), Clinical Child Psychology (CCP), Clinical Neuropsychology .

What is a clinical practice guideline? APA defines two main types of guidelines: 1. Professional practice guidelines-"recommendations to professionals concerning their conduct and the issues to be considered in particular areas of clinical practice" (APA, 2002 ). 2. Clinical practice guidelines-"provide specific recommendations about

NOTE: Under HCSC’s medical policy, hair drug testing and oral fluid drug testing are considered experimental, investigational and/or unproven in outpatient pain management and substance use disorder treatment. Definitive Drug Testing . The below listed codes are tests utilizing drug identification

B. Google Drive Folder Contents Tracking Form C. Guidelines Business Plan C. Guidelines Clinical Case Studies C. Guidelines Clinical Case Study Presentation Template C. Guidelines Community Rotation Example Activities C. Guidelines Menu Theme Meal Project C. Guidelines Poster T

guidelines, which presented a clinical ventilator allocation protocol for adults and included a brief section on the legal issues associated with implementing the guidelines. This update of the Guidelines consists of four chapters: (1) the adult guidelines, (2) the pediatric guidelines, (3) the neonatal guidelines, and (4) legal considerations.

o Additif alimentaire. 41 Intrants alimentaires: o Matière première : matière unique ou principale soumise à la transformation Unique : blé en minoterie, betterave ou canne en sucrerie Principale en volume : lait pour le yaourt, eau pour les boissons gazeuses Principale en valeur : sucre pour les boissons gazeuses 1. Chapitre introductif 1.4- Intrants et produits des IAA. 42 o Ingrédient .